Name | Number of supported studies | Average coverage | |
---|---|---|---|
kidney loop of Henle epithelial cell | 7 studies | 43% ± 25% | |
kidney connecting tubule epithelial cell | 5 studies | 75% ± 30% | |
renal alpha-intercalated cell | 5 studies | 52% ± 9% | |
renal principal cell | 5 studies | 60% ± 33% | |
kidney distal convoluted tubule epithelial cell | 4 studies | 69% ± 27% | |
epithelial cell of proximal tubule | 3 studies | 21% ± 7% |
Insufficient scRNA-seq data for expression of CDH16 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 53327.16 | 89 / 89 | 97% | 286.19 | 877 / 901 |
thymus | 100% | 4738.75 | 653 / 653 | 21% | 14.48 | 126 / 605 |
heart | 53% | 41.59 | 453 / 861 | 0% | 0 | 0 / 0 |
esophagus | 41% | 273.73 | 592 / 1445 | 7% | 2.87 | 13 / 183 |
intestine | 34% | 50.40 | 329 / 966 | 5% | 2.12 | 25 / 527 |
muscle | 34% | 48.91 | 275 / 803 | 0% | 0 | 0 / 0 |
uterus | 15% | 16.11 | 25 / 170 | 11% | 12.33 | 52 / 459 |
ovary | 6% | 9.24 | 11 / 180 | 9% | 7.15 | 38 / 430 |
lung | 12% | 6.66 | 67 / 578 | 2% | 0.86 | 24 / 1155 |
liver | 7% | 4.41 | 16 / 226 | 6% | 2.87 | 23 / 406 |
blood vessel | 11% | 3.96 | 144 / 1335 | 0% | 0 | 0 / 0 |
stomach | 4% | 2.02 | 16 / 359 | 5% | 1.69 | 14 / 286 |
skin | 8% | 3.14 | 139 / 1809 | 0% | 0 | 0 / 472 |
tonsil | 0% | 0 | 0 / 0 | 7% | 1.03 | 3 / 45 |
prostate | 4% | 2.67 | 10 / 245 | 0% | 0 | 0 / 502 |
pancreas | 1% | 1.56 | 3 / 328 | 2% | 0.88 | 3 / 178 |
adipose | 2% | 1.87 | 30 / 1204 | 0% | 0 | 0 / 0 |
breast | 2% | 1.38 | 8 / 459 | 0% | 0 | 0 / 1118 |
spleen | 2% | 0.73 | 4 / 241 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.59 | 7 / 504 |
brain | 1% | 0.61 | 21 / 2642 | 0% | 0 | 0 / 705 |
adrenal gland | 1% | 0.25 | 2 / 258 | 0% | 0 | 0 / 230 |
peripheral blood | 0% | 0.03 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
GO_0007155 | Biological process | cell adhesion |
GO_0016339 | Biological process | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CDH16 |
Protein name | Cadherin 16 Cadherin-16 (Kidney-specific cadherin) (Ksp-cadherin) |
Synonyms | UNQ695/PRO1340 |
Description | FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. |
Accessions | ENST00000565796.5 [O75309-4] ENST00000299752.9 [O75309-1] O75309 ENST00000568698.5 ENST00000568632.5 [O75309-3] H3BSV3 ENST00000570262.5 ENST00000565235.2 ENST00000567009.5 ENST00000567269.5 J3QLA1 A0A0B4J288 ENST00000394055.7 [O75309-2] H3BSG2 I3L418 |